Shockwave Medical announced the FDA clearance and full U.S. launch of its peripheral intravascular lithotripsy catheter designed to treat calcified femoropopliteal and below-the-knee peripheral artery disease.
The catheter (Shockwave E8) is also designed to treat patients with chronic limb-threatening ischemia, the most advanced and serious form of PAD, according to a press release issued by the company.
The catheter is designed to deliver 400 pulses twice per second from eight emitters across an 80 mm balloon, and with catheter working length of 150 cm, intravascular lithotripsy treatment can